The first quarter of 2022 delivered ten reported gastroenterology practice acquisitions, continuing the high level of M&A activity we saw last year Several deals were announced in the first few weeks of the year, likely spilling over from efforts to close in 2021.
The first quarter of 2022 delivered two reported ENT practice acquisitions, coming down from a flurry of deal activity to end last year.
The 4th quarter of 2021 delivered two reported cardiology platform acquisitions, signaling an imminent wave of increasing private equity investments into the specialty.
The first quarter of 2022 delivered thirty-five reported behavioral health acquisitions, returning to average deal volume after a spike in activity to end 2021. Mental health and addiction treatment continue to be at the forefront of consolidation. We will highlight a few notable deals from the period.
The 1st quarter of 2022 delivered two reported cardiology partnerships for this specialty in the Early Pioneering lifecycle stage PE interest remains consistent and seems to be building
Washington, DC, (February 14, 2022) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture, and corporate finance services, announced today that Vista Eye Specialists, an ophthalmologic and optomet- ric practice, has been acquired by Atlantic Vision Partners (“AVP”), a portfolio company of Sheridan Capital Partners. FOCUS managing directors, Eric Yetter and Andy Snyder, advised Vista Eye Specialists in this partnership.They are among the most active advisors to ophthal- mologists in transactions with private equity-backed organizations.
Washington, DC, (January 27, 2022) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, dives- titure, and corporate finance services, announced today that Velmed, Inc. (“Velmed”), a South Carolina-based manufacturer of medical devices for the operating room and sterile processing department, has been acquired by Canadian Hospital Specialties Limited (“CHS”), a portfolio company of Flexpoint Ford, LLC. FOCUS advised Velmed in this transaction.
Securities transactions conducted by FOCUS Securities LLC, an affiliated company, registered broker-dealer and member FINRA/SIPC © 2025 FOCUS Investment Banking LLC
Securities transactions conducted by FOCUS Securities LLC, an affiliated company, registered broker-dealer and member FINRA/SIPC © 2025 FOCUS Investment Banking LLC
